陆梅 - 北京理工大学 - 前沿交叉科学研究院

个人简介

博士 2016-2019，沈阳药科大学，药剂学硕士 2013-2016，沈阳药科大学，药剂学学士 2009-2013，沈阳药科大学，药学

研究领域

载核酸类药物（如siRNA、mRNA）的智能响应型外泌体用于肿瘤免疫治疗的研究 mRNA疫苗及其用于传染性疾病防治的研究

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Biomaterials, 2020, 242: 119925. Chin. Chem. Lett., 2021, 32: 1010-1016. M. Lu, X. Zhao, H. Xing, et al. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery. Acta Biomater. 2019, 96:517-536. M. Lu, X. Zhao, H. Xing, et al. Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: Implications for therapeutic delivery. Acta Biomater., 2018, 76: 1-20. M. Lu, X. Zhao, H. Xing, et al. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int. J. Pharm., 2018, 550:100-113. M. Lu, H. Xing, Z. Yang, et al. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities. Eur. J. Pharm. Biopharm., 2017, 119: 381-395. M. Lu, H. Xing, Z. Xun, et al. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems. Eur. J. Pharm. Sci., 2018, 121: 34-46. M. Lu, H. Xing, Z. Xun, et al. Exosome-based small RNA delivery: Progress and prospects. Asian J. Pharm. Sci., 2018, 13: 1-11. M. Lu, H. Xing, T. Yang, et al. Dissolution enhancement of tadalafil by liquisolid technique. Pharm. Dev. Technol., 2017, 22: 77-89. M. Lu, H. Xing, X. Chen, et al. Advance in bioequivalence assessment of topical dermatological products, Asian J. Pharm. Sci., 2016, 11: 700-707. M. Lu, H. Xing, J. Jang, et al. Liquisolid technique and its applications in pharmaceutics, Asian J. Pharm. Sci., 2017, 12: 115-123. 著作《Design and delivery of siRNA therapeutics》, Springer Nature，2021.